L V Prasad Eye Institute (LVPEI) is recognised as one of the forefront global centres for corneal neurotization surgery that has performed over 40 surgeries with surgical success rates similar to other established centres worldwide.
Meril, a global leader in advanced medical solutions, brought together some of India’s most distinguished oncology experts at OncoXchange, a high-impact panel discussion held at Meril Academy, Aloft Hotel, Aerocity, New Delhi.
.jpeg)
India’s biopharmaceutical sector is witnessing a significant shift as Biocon intensifies its dual focus on insulin and GLP-1 therapies, positioning itself strongly in two high-growth segments. With decades of expertise in biosimilar insulins, the Ben
AbbVie announced that it has submitted a supplemental New Drug Application to the U.S. FDA for a new fixed-duration, all-oral combination therapy with Venclexta and acalabrutinib for the treatment of previously untreated chronic lymphocytic...
.jpeg)
Leading DNA sequencing and genomics company Illumina Inc. has introduced TruSight Oncology 500 version 2 (TSO 500 v2), the next version of their flagship cancer research test. Comprehensive genomic profiling (CGP), which provides comprehensive molecu
In a remarkable boost for innovation in antibiotics, Wockhardt's Zaynich has been mentioned in a top medical journal in the UK following a remarkable recovery case of a liver transplant patient with a pan-drug-resistant infection...
In a significant shift in mosquito-borne disease trends, Chikungunya cases have now surpassed Dengue in Bhopal, raising red flags over possible underreporting and gaps in surveillance. As of July 2025, the city has continuted to have equally...
Apollo AyurVAID, a part of Apollo Hospitals Group, has announced the launch of India’s First line of “Tested Safe” Ayurveda products, setting a new benchmark in the traditional medicine space. The line includes classical prescription formulations...
As part of a major step to digitisation of India’s pharmaceutical regulatory processes, the Central Drugs Standard Control Organisation (CDSCO) announced that effective 15 July 2025, all applications for World Health Organisation Good Manufacturin...
.jpeg)
A new study has shown that many widely used generic chemotherapy medicines around the world have failed quality testing. This raises serious doubts about the safety and efficacy of cancer therapy in more than 100 countries. The affected drugs...
.jpg)
.jpg)
, CDSCO.jpg)